Compare Enveric Biosciences Inc (ENVB) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Starbucks Corp — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Starbucks Corp trades at $108.59 (market cap $119.79B). The key difference: Starbucks Corp is far larger — about 22516.9× Enveric Biosciences Inc's market cap, and Starbucks Corp pays a 2.36% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | SBUX | |
|---|---|---|
Market Cap | $5.32M | $119.79B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $107.34 |
52-Week Low | $1.28 | $78.46 |
Enterprise Value | $408.82K | $142.48B |
Volume | — | 7,493,833 |
Dividend Yield | — | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Starbucks (SBUX) trades at $106.17, down 1.09% on the day, as the stock consolidates near its 52-week high. The technical picture is bullish with moving averages aligned positively, while fundamentals show mixed signals with recent earnings beats but declining net margins. The company is actively pursuing cost-cutting initiatives, including developing in-house AI tools to reduce its $400 million annual software spend, as reported by Bloomberg on July 10, 2026. Revenue growth remains steady at $37.18B for 2025, though profitability has compressed.
The outlook balances operational turnaround efforts against valuation concerns. Analyst consensus is moderately bullish with a $108.31 price target, but the high P/E ratio of 80.24 suggests limited near-term upside. Key risks include execution of cost-saving initiatives, competitive pressures, and consumer spending sensitivity. The dividend yield of approximately 2.3% provides income support while investors await margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
